Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 6,638 | 6,186 | 6,094 | 6,693 | 6,111 |
| Cost of Goods | 3,961 | 3,787 | 4,793 | 3,802 | 3,121 |
| Gross Profit | 2,677 | 2,399 | 1,301 | 2,891 | 2,990 |
| Operating Expenses | 6,411 | 5,321 | 7,599 | 3,940 | 2,593 |
| Operating Income | -2,772 | -2,135 | -5,505 | -247 | 517 |
| Interest Expense | 1,097 | 1,210 | 3,489 | 629 | 468 |
| Other Income | 0 | 0 | -52 | 43 | 0 |
| Pre-tax Income | -3,869 | -3,345 | -9,046 | -834 | 49 |
| Income Tax | 3 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -3,873 | -3,345 | -9,046 | -834 | 49 |
| Minority Interests | 5 | N/A | N/A | N/A | N/A |
| Net Income | $-3,878 | $-3,345 | $-9,046 | $-834 | $49 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.11 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.11 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.11 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.11 | -0.01 | 0.00 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.04 | -0.11 | N/A | N/A |
| EBITDA(a) | $-1,564 | $-703 | $-1,319 | $169 | $788 |